[Involvement of Insulin resistance in the pathogenesis of hypertensive target-organ damage].
Ura
Nobuyuki
N
Second Department of Internal Medicine, Sapporo Medical University School of Medicine.
Shimamoto
Kazuaki
K
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology*; D002455:Cell Division; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology; D007328:Insulin / Q000502:physiology; D007333:Insulin Resistance; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000502:physiology; D052250:Nitric Oxide Synthase Type III; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism
D007328:Insulin; D017395:Plasminogen Activator Inhibitor 1; D009569:Nitric Oxide; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D019869:Phosphatidylinositol 3-Kinases; D020928:Mitogen-Activated Protein Kinases